Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wick

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
Human Mutation|March 1, 2020
Int22h1/Int22h2-mediated Xq28 duplication syndrome: de novo duplications, prenatal diagnoses, and additional phenotypic featuresRami A Ballout, Cheryl Dickerson, Myra J Wick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2016
Targeting MDM2 for Treatment of Adenoid Cystic CarcinomaKristy A Warner, Felipe Nör, Gerson A Acasigua, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 10, 2025
Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Joanne Ngeow, Jianbang Chiang, Esteban Astiazaran-Symonds, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine WarheadsKrista Kinneer, John Meekin, Arnaud C Tiberghien, et al.
The American Journal of Pathology|February 24, 2009
Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxiaEdward C Dempsey, Marilee J Wick, Vijaya Karoor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 InhibitorsRenata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, et al.
Molecular Cancer Therapeutics|September 24, 2017
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)Ursula A Germann, Brinley F Furey, William Markland, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune CellsJoseph G Skeate, Nicholas J Slipek, Walker S Lahr, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|January 19, 2026
Ultrasound and SNP-based cell-free DNA zygosity testing in twin pregnanciesRuben Quintero, K Joseph Hurt, Neeta L Vora, et al.
JAMA|April 11, 2013
Long QT syndrome-associated mutations in intrauterine fetal deathLia Crotti, David J Tester, Wendy M White, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Human Mutation|March 1, 2020
Int22h1/Int22h2-mediated Xq28 duplication syndrome: de novo duplications, prenatal diagnoses, and additional phenotypic featuresRami A Ballout, Cheryl Dickerson, Myra J Wick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2016
Targeting MDM2 for Treatment of Adenoid Cystic CarcinomaKristy A Warner, Felipe Nör, Gerson A Acasigua, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 10, 2025
Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Joanne Ngeow, Jianbang Chiang, Esteban Astiazaran-Symonds, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine WarheadsKrista Kinneer, John Meekin, Arnaud C Tiberghien, et al.
The American Journal of Pathology|February 24, 2009
Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxiaEdward C Dempsey, Marilee J Wick, Vijaya Karoor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 InhibitorsRenata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, et al.
Molecular Cancer Therapeutics|September 24, 2017
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)Ursula A Germann, Brinley F Furey, William Markland, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune CellsJoseph G Skeate, Nicholas J Slipek, Walker S Lahr, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|January 19, 2026
Ultrasound and SNP-based cell-free DNA zygosity testing in twin pregnanciesRuben Quintero, K Joseph Hurt, Neeta L Vora, et al.
JAMA|April 11, 2013
Long QT syndrome-associated mutations in intrauterine fetal deathLia Crotti, David J Tester, Wendy M White, et al.
Pageof 17